mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-10 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-10 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-08 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-07 |